抗アレルギー薬のグローバル市場インサイト・予測（～2028年）

• 英文タイトル：Global Anti-allergic Drugs Market Insights and Forecast to 2028

• レポートコード：QY2203B09200 • 出版社/出版日：QYResearch / 2022年3月 • レポート形態：英文、PDF、114ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥735,000 (USD4,900)	▷ お問い合わせ
Multi User	￥1,102,500 (USD7,350)	▷ お問い合わせ
Enterprise License	￥1,470,000 (USD9,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

新型コロナウイルス感染症のパンデミックにより、世界の抗アレルギー薬の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に抗アレルギー薬の世界市場のxxx％を占める「経口薬」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「オンライン」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。 中国の抗アレルギー薬の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの抗アレルギー薬市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの抗アレルギー薬市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。 抗アレルギー薬のグローバル主要メーカーには、Sanofi、Johnson And Johnson、Merck、Teva、GlaxoSmithKline、Bayer、Sun Pharma、UCB Pharma、Yangtze River Pharmaceutical Group、Hainan Poly Pharm、Chongqing Huapont Pharmaceutical、Dawnraysなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 抗アレルギー薬市場は、種類と用途によって区分されます。世界の抗アレルギー薬市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。 【種類別セグメント】 経口薬、非経口薬 【用途別セグメント】 オンライン、オフライン 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 抗アレルギー薬製品概要 - 種類別市場（経口薬、非経口薬） - 用途別市場（オンライン、オフライン） - 調査の目的 ・エグゼクティブサマリー - 世界の抗アレルギー薬販売量予測2017-2028 - 世界の抗アレルギー薬売上予測2017-2028 - 抗アレルギー薬の地域別販売量 - 抗アレルギー薬の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別抗アレルギー薬販売量 - 主要メーカー別抗アレルギー薬売上 - 主要メーカー別抗アレルギー薬価格 - 競争状況の分析 - 企業M&A動向 ・種類別市場規模（経口薬、非経口薬） - 抗アレルギー薬の種類別販売量 - 抗アレルギー薬の種類別売上 - 抗アレルギー薬の種類別価格 ・用途別市場規模（オンライン、オフライン） - 抗アレルギー薬の用途別販売量 - 抗アレルギー薬の用途別売上 - 抗アレルギー薬の用途別価格 ・北米市場 - 北米の抗アレルギー薬市場規模（種類別、用途別） - 主要国別の抗アレルギー薬市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの抗アレルギー薬市場規模（種類別、用途別） - 主要国別の抗アレルギー薬市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の抗アレルギー薬市場規模（種類別、用途別） - 主要国別の抗アレルギー薬市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の抗アレルギー薬市場規模（種類別、用途別） - 主要国別の抗アレルギー薬市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの抗アレルギー薬市場規模（種類別、用途別） - 主要国別の抗アレルギー薬市場規模（トルコ、サウジアラビア） ・企業情報 Sanofi、Johnson And Johnson、Merck、Teva、GlaxoSmithKline、Bayer、Sun Pharma、UCB Pharma、Yangtze River Pharmaceutical Group、Hainan Poly Pharm、Chongqing Huapont Pharmaceutical、Dawnrays ・産業チェーン及び販売チャネル分析 - 抗アレルギー薬の産業チェーン分析 - 抗アレルギー薬の原材料 - 抗アレルギー薬の生産プロセス - 抗アレルギー薬の販売及びマーケティング - 抗アレルギー薬の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 抗アレルギー薬の産業動向 - 抗アレルギー薬のマーケットドライバー - 抗アレルギー薬の課題 - 抗アレルギー薬の阻害要因 ・主な調査結果

Market Analysis and Insights: Global Anti-allergic Drugs Market
The global Anti-allergic Drugs market size is projected to reach US$ 14400 million by 2028, from US$ 10980 million in 2021, at a CAGR of 3.9% during 2022-2028.
Global Anti-allergic Drugs includes Sanofi, Johnson And Johnson, etc. Global top two companies hold a share over 10%. North America is the largest market, with a share about 40%, followed by Europe and Asia-Pacific with the share about 30 and 20.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Anti-allergic Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Anti-allergic Drugs market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Anti-allergic Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Anti-allergic Drugs market.
Global Anti-allergic Drugs Scope and Market Size
Anti-allergic Drugs market is segmented by players, region (country), by Type and by Sales Channel. Players, stakeholders, and other participants in the global Anti-allergic Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Sales Channel for the period 2017-2028.
Segment by Type
Oral Drugs
Non-Oral Drugs
Segment by Sales Channel
Online
Offline
By Company
Sanofi
Johnson And Johnson
Merck
Teva
GlaxoSmithKline
Bayer
Sun Pharma
UCB Pharma
Yangtze River Pharmaceutical Group
Hainan Poly Pharm
Chongqing Huapont Pharmaceutical
Dawnrays
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

レポート目次

---

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anti-allergic Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Oral Drugs
1.2.3 Non-Oral Drugs
1.3 Market by Sales Channel
1.3.1 Global Anti-allergic Drugs Market Size Growth Rate by Sales Channel, 2017 VS 2021 VS 2028
1.3.2 Online
1.3.3 Offline
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Anti-allergic Drugs Market Perspective (2017-2028)
2.2 Anti-allergic Drugs Growth Trends by Region
2.2.1 Anti-allergic Drugs Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Anti-allergic Drugs Historic Market Size by Region (2017-2022)
2.2.3 Anti-allergic Drugs Forecasted Market Size by Region (2023-2028)
2.3 Anti-allergic Drugs Market Dynamics
2.3.1 Anti-allergic Drugs Industry Trends
2.3.2 Anti-allergic Drugs Market Drivers
2.3.3 Anti-allergic Drugs Market Challenges
2.3.4 Anti-allergic Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Anti-allergic Drugs Players by Revenue
3.1.1 Global Top Anti-allergic Drugs Players by Revenue (2017-2022)
3.1.2 Global Anti-allergic Drugs Revenue Market Share by Players (2017-2022)
3.2 Global Anti-allergic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Anti-allergic Drugs Revenue
3.4 Global Anti-allergic Drugs Market Concentration Ratio
3.4.1 Global Anti-allergic Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anti-allergic Drugs Revenue in 2021
3.5 Anti-allergic Drugs Key Players Head office and Area Served
3.6 Key Players Anti-allergic Drugs Product Solution and Service
3.7 Date of Enter into Anti-allergic Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Anti-allergic Drugs Breakdown Data by Type
4.1 Global Anti-allergic Drugs Historic Market Size by Type (2017-2022)
4.2 Global Anti-allergic Drugs Forecasted Market Size by Type (2023-2028)
5 Anti-allergic Drugs Breakdown Data by Sales Channel
5.1 Global Anti-allergic Drugs Historic Market Size by Sales Channel (2017-2022)
5.2 Global Anti-allergic Drugs Forecasted Market Size by Sales Channel (2023-2028)
6 North America
6.1 North America Anti-allergic Drugs Market Size (2017-2028)
6.2 North America Anti-allergic Drugs Market Size by Type
6.2.1 North America Anti-allergic Drugs Market Size by Type (2017-2022)
6.2.2 North America Anti-allergic Drugs Market Size by Type (2023-2028)
6.2.3 North America Anti-allergic Drugs Market Share by Type (2017-2028)
6.3 North America Anti-allergic Drugs Market Size by Sales Channel
6.3.1 North America Anti-allergic Drugs Market Size by Sales Channel (2017-2022)
6.3.2 North America Anti-allergic Drugs Market Size by Sales Channel (2023-2028)
6.3.3 North America Anti-allergic Drugs Market Share by Sales Channel (2017-2028)
6.4 North America Anti-allergic Drugs Market Size by Country
6.4.1 North America Anti-allergic Drugs Market Size by Country (2017-2022)
6.4.2 North America Anti-allergic Drugs Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Anti-allergic Drugs Market Size (2017-2028)
7.2 Europe Anti-allergic Drugs Market Size by Type
7.2.1 Europe Anti-allergic Drugs Market Size by Type (2017-2022)
7.2.2 Europe Anti-allergic Drugs Market Size by Type (2023-2028)
7.2.3 Europe Anti-allergic Drugs Market Share by Type (2017-2028)
7.3 Europe Anti-allergic Drugs Market Size by Sales Channel
7.3.1 Europe Anti-allergic Drugs Market Size by Sales Channel (2017-2022)
7.3.2 Europe Anti-allergic Drugs Market Size by Sales Channel (2023-2028)
7.3.3 Europe Anti-allergic Drugs Market Share by Sales Channel (2017-2028)
7.4 Europe Anti-allergic Drugs Market Size by Country
7.4.1 Europe Anti-allergic Drugs Market Size by Country (2017-2022)
7.4.2 Europe Anti-allergic Drugs Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Anti-allergic Drugs Market Size (2017-2028)
8.2 Asia-Pacific Anti-allergic Drugs Market Size by Type
8.2.1 Asia-Pacific Anti-allergic Drugs Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Anti-allergic Drugs Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Anti-allergic Drugs Market Share by Type (2017-2028)
8.3 Asia-Pacific Anti-allergic Drugs Market Size by Sales Channel
8.3.1 Asia-Pacific Anti-allergic Drugs Market Size by Sales Channel (2017-2022)
8.3.2 Asia-Pacific Anti-allergic Drugs Market Size by Sales Channel (2023-2028)
8.3.3 Asia-Pacific Anti-allergic Drugs Market Share by Sales Channel (2017-2028)
8.4 Asia-Pacific Anti-allergic Drugs Market Size by Region
8.4.1 Asia-Pacific Anti-allergic Drugs Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Anti-allergic Drugs Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Anti-allergic Drugs Market Size (2017-2028)
9.2 Latin America Anti-allergic Drugs Market Size by Type
9.2.1 Latin America Anti-allergic Drugs Market Size by Type (2017-2022)
9.2.2 Latin America Anti-allergic Drugs Market Size by Type (2023-2028)
9.2.3 Latin America Anti-allergic Drugs Market Share by Type (2017-2028)
9.3 Latin America Anti-allergic Drugs Market Size by Sales Channel
9.3.1 Latin America Anti-allergic Drugs Market Size by Sales Channel (2017-2022)
9.3.2 Latin America Anti-allergic Drugs Market Size by Sales Channel (2023-2028)
9.3.3 Latin America Anti-allergic Drugs Market Share by Sales Channel (2017-2028)
9.4 Latin America Anti-allergic Drugs Market Size by Country
9.4.1 Latin America Anti-allergic Drugs Market Size by Country (2017-2022)
9.4.2 Latin America Anti-allergic Drugs Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Anti-allergic Drugs Market Size (2017-2028)
10.2 Middle East & Africa Anti-allergic Drugs Market Size by Type
10.2.1 Middle East & Africa Anti-allergic Drugs Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Anti-allergic Drugs Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Anti-allergic Drugs Market Share by Type (2017-2028)
10.3 Middle East & Africa Anti-allergic Drugs Market Size by Sales Channel
10.3.1 Middle East & Africa Anti-allergic Drugs Market Size by Sales Channel (2017-2022)
10.3.2 Middle East & Africa Anti-allergic Drugs Market Size by Sales Channel (2023-2028)
10.3.3 Middle East & Africa Anti-allergic Drugs Market Share by Sales Channel (2017-2028)
10.4 Middle East & Africa Anti-allergic Drugs Market Size by Country
10.4.1 Middle East & Africa Anti-allergic Drugs Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Anti-allergic Drugs Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Sanofi
11.1.1 Sanofi Company Details
11.1.2 Sanofi Business Overview
11.1.3 Sanofi Anti-allergic Drugs Introduction
11.1.4 Sanofi Revenue in Anti-allergic Drugs Business (2017-2022)
11.1.5 Sanofi Recent Developments
11.2 Johnson And Johnson
11.2.1 Johnson And Johnson Company Details
11.2.2 Johnson And Johnson Business Overview
11.2.3 Johnson And Johnson Anti-allergic Drugs Introduction
11.2.4 Johnson And Johnson Revenue in Anti-allergic Drugs Business (2017-2022)
11.2.5 Johnson And Johnson Recent Developments
11.3 Merck
11.3.1 Merck Company Details
11.3.2 Merck Business Overview
11.3.3 Merck Anti-allergic Drugs Introduction
11.3.4 Merck Revenue in Anti-allergic Drugs Business (2017-2022)
11.3.5 Merck Recent Developments
11.4 Teva
11.4.1 Teva Company Details
11.4.2 Teva Business Overview
11.4.3 Teva Anti-allergic Drugs Introduction
11.4.4 Teva Revenue in Anti-allergic Drugs Business (2017-2022)
11.4.5 Teva Recent Developments
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Details
11.5.2 GlaxoSmithKline Business Overview
11.5.3 GlaxoSmithKline Anti-allergic Drugs Introduction
11.5.4 GlaxoSmithKline Revenue in Anti-allergic Drugs Business (2017-2022)
11.5.5 GlaxoSmithKline Recent Developments
11.6 Bayer
11.6.1 Bayer Company Details
11.6.2 Bayer Business Overview
11.6.3 Bayer Anti-allergic Drugs Introduction
11.6.4 Bayer Revenue in Anti-allergic Drugs Business (2017-2022)
11.6.5 Bayer Recent Developments
11.7 Sun Pharma
11.7.1 Sun Pharma Company Details
11.7.2 Sun Pharma Business Overview
11.7.3 Sun Pharma Anti-allergic Drugs Introduction
11.7.4 Sun Pharma Revenue in Anti-allergic Drugs Business (2017-2022)
11.7.5 Sun Pharma Recent Developments
11.8 UCB Pharma
11.8.1 UCB Pharma Company Details
11.8.2 UCB Pharma Business Overview
11.8.3 UCB Pharma Anti-allergic Drugs Introduction
11.8.4 UCB Pharma Revenue in Anti-allergic Drugs Business (2017-2022)
11.8.5 UCB Pharma Recent Developments
11.9 Yangtze River Pharmaceutical Group
11.9.1 Yangtze River Pharmaceutical Group Company Details
11.9.2 Yangtze River Pharmaceutical Group Business Overview
11.9.3 Yangtze River Pharmaceutical Group Anti-allergic Drugs Introduction
11.9.4 Yangtze River Pharmaceutical Group Revenue in Anti-allergic Drugs Business (2017-2022)
11.9.5 Yangtze River Pharmaceutical Group Recent Developments
11.10 Hainan Poly Pharm
11.10.1 Hainan Poly Pharm Company Details
11.10.2 Hainan Poly Pharm Business Overview
11.10.3 Hainan Poly Pharm Anti-allergic Drugs Introduction
11.10.4 Hainan Poly Pharm Revenue in Anti-allergic Drugs Business (2017-2022)
11.10.5 Hainan Poly Pharm Recent Developments
11.11 Chongqing Huapont Pharmaceutical
11.11.1 Chongqing Huapont Pharmaceutical Company Details
11.11.2 Chongqing Huapont Pharmaceutical Business Overview
11.11.3 Chongqing Huapont Pharmaceutical Anti-allergic Drugs Introduction
11.11.4 Chongqing Huapont Pharmaceutical Revenue in Anti-allergic Drugs Business (2017-2022)
11.11.5 Chongqing Huapont Pharmaceutical Recent Developments
11.12 Dawnrays
11.12.1 Dawnrays Company Details
11.12.2 Dawnrays Business Overview
11.12.3 Dawnrays Anti-allergic Drugs Introduction
11.12.4 Dawnrays Revenue in Anti-allergic Drugs Business (2017-2022)
11.12.5 Dawnrays Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

List of Tables
Table 1. Global Anti-allergic Drugs Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Oral Drugs
Table 3. Key Players of Non-Oral Drugs
Table 4. Global Anti-allergic Drugs Market Size Growth Rate by Sales Channel (US$ Million), 2017 VS 2021 VS 2028
Table 5. Global Anti-allergic Drugs Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Anti-allergic Drugs Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Anti-allergic Drugs Market Share by Region (2017-2022)
Table 8. Global Anti-allergic Drugs Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Anti-allergic Drugs Market Share by Region (2023-2028)
Table 10. Anti-allergic Drugs Market Trends
Table 11. Anti-allergic Drugs Market Drivers
Table 12. Anti-allergic Drugs Market Challenges
Table 13. Anti-allergic Drugs Market Restraints
Table 14. Global Anti-allergic Drugs Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Anti-allergic Drugs Revenue Share by Players (2017-2022)
Table 16. Global Top Anti-allergic Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-allergic Drugs as of 2021)
Table 17. Ranking of Global Top Anti-allergic Drugs Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Anti-allergic Drugs Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Anti-allergic Drugs Product Solution and Service
Table 21. Date of Enter into Anti-allergic Drugs Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Anti-allergic Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Anti-allergic Drugs Revenue Market Share by Type (2017-2022)
Table 25. Global Anti-allergic Drugs Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Anti-allergic Drugs Revenue Market Share by Type (2023-2028)
Table 27. Global Anti-allergic Drugs Market Size by Sales Channel (2017-2022) & (US$ Million)
Table 28. Global Anti-allergic Drugs Revenue Share by Sales Channel (2017-2022)
Table 29. Global Anti-allergic Drugs Forecasted Market Size by Sales Channel (2023-2028) & (US$ Million)
Table 30. Global Anti-allergic Drugs Revenue Share by Sales Channel (2023-2028)
Table 31. North America Anti-allergic Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 32. North America Anti-allergic Drugs Market Size by Type (2023-2028) & (US$ Million)
Table 33. North America Anti-allergic Drugs Market Size by Sales Channel (2017-2022) & (US$ Million)
Table 34. North America Anti-allergic Drugs Market Size by Sales Channel (2023-2028) & (US$ Million)
Table 35. North America Anti-allergic Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 36. North America Anti-allergic Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 37. Europe Anti-allergic Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 38. Europe Anti-allergic Drugs Market Size by Type (2023-2028) & (US$ Million)
Table 39. Europe Anti-allergic Drugs Market Size by Sales Channel (2017-2022) & (US$ Million)
Table 40. Europe Anti-allergic Drugs Market Size by Sales Channel (2023-2028) & (US$ Million)
Table 41. Europe Anti-allergic Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 42. Europe Anti-allergic Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 43. Asia Pacific Anti-allergic Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 44. Asia Pacific Anti-allergic Drugs Market Size by Type (2023-2028) & (US$ Million)
Table 45. Asia Pacific Anti-allergic Drugs Market Size by Sales Channel (2017-2022) & (US$ Million)
Table 46. Asia Pacific Anti-allergic Drugs Market Size by Sales Channel (2023-2028) & (US$ Million)
Table 47. Asia Pacific Anti-allergic Drugs Market Size by Region (2017-2022) & (US$ Million)
Table 48. Asia Pacific Anti-allergic Drugs Market Size by Region (2023-2028) & (US$ Million)
Table 49. Latin America Anti-allergic Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 50. Latin America Anti-allergic Drugs Market Size by Type (2023-2028) & (US$ Million)
Table 51. Latin America Anti-allergic Drugs Market Size by Sales Channel (2017-2022) & (US$ Million)
Table 52. Latin America Anti-allergic Drugs Market Size by Sales Channel (2023-2028) & (US$ Million)
Table 53. Latin America Anti-allergic Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 54. Latin America Anti-allergic Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 55. Middle East and Africa Anti-allergic Drugs Market Size by Type (2017-2022) & (US$ Million)
Table 56. Middle East and Africa Anti-allergic Drugs Market Size by Type (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Anti-allergic Drugs Market Size by Sales Channel (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Anti-allergic Drugs Market Size by Sales Channel (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Anti-allergic Drugs Market Size by Country (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Anti-allergic Drugs Market Size by Country (2023-2028) & (US$ Million)
Table 61. Sanofi Company Details
Table 62. Sanofi Business Overview
Table 63. Sanofi Anti-allergic Drugs Product
Table 64. Sanofi Revenue in Anti-allergic Drugs Business (2017-2022) & (US$ Million)
Table 65. Sanofi Recent Developments
Table 66. Johnson And Johnson Company Details
Table 67. Johnson And Johnson Business Overview
Table 68. Johnson And Johnson Anti-allergic Drugs Product
Table 69. Johnson And Johnson Revenue in Anti-allergic Drugs Business (2017-2022) & (US$ Million)
Table 70. Johnson And Johnson Recent Developments
Table 71. Merck Company Details
Table 72. Merck Business Overview
Table 73. Merck Anti-allergic Drugs Product
Table 74. Merck Revenue in Anti-allergic Drugs Business (2017-2022) & (US$ Million)
Table 75. Merck Recent Developments
Table 76. Teva Company Details
Table 77. Teva Business Overview
Table 78. Teva Anti-allergic Drugs Product
Table 79. Teva Revenue in Anti-allergic Drugs Business (2017-2022) & (US$ Million)
Table 80. Teva Recent Developments
Table 81. GlaxoSmithKline Company Details
Table 82. GlaxoSmithKline Business Overview
Table 83. GlaxoSmithKline Anti-allergic Drugs Product
Table 84. GlaxoSmithKline Revenue in Anti-allergic Drugs Business (2017-2022) & (US$ Million)
Table 85. GlaxoSmithKline Recent Developments
Table 86. Bayer Company Details
Table 87. Bayer Business Overview
Table 88. Bayer Anti-allergic Drugs Product
Table 89. Bayer Revenue in Anti-allergic Drugs Business (2017-2022) & (US$ Million)
Table 90. Bayer Recent Developments
Table 91. Sun Pharma Company Details
Table 92. Sun Pharma Business Overview
Table 93. Sun Pharma Anti-allergic Drugs Product
Table 94. Sun Pharma Revenue in Anti-allergic Drugs Business (2017-2022) & (US$ Million)
Table 95. Sun Pharma Recent Developments
Table 96. UCB Pharma Company Details
Table 97. UCB Pharma Business Overview
Table 98. UCB Pharma Anti-allergic Drugs Product
Table 99. UCB Pharma Revenue in Anti-allergic Drugs Business (2017-2022) & (US$ Million)
Table 100. UCB Pharma Recent Developments
Table 101. Yangtze River Pharmaceutical Group Company Details
Table 102. Yangtze River Pharmaceutical Group Business Overview
Table 103. Yangtze River Pharmaceutical Group Anti-allergic Drugs Product
Table 104. Yangtze River Pharmaceutical Group Revenue in Anti-allergic Drugs Business (2017-2022) & (US$ Million)
Table 105. Yangtze River Pharmaceutical Group Recent Developments
Table 106. Hainan Poly Pharm Company Details
Table 107. Hainan Poly Pharm Business Overview
Table 108. Hainan Poly Pharm Anti-allergic Drugs Product
Table 109. Hainan Poly Pharm Revenue in Anti-allergic Drugs Business (2017-2022) & (US$ Million)
Table 110. Hainan Poly Pharm Recent Developments
Table 111. Chongqing Huapont Pharmaceutical Company Details
Table 112. Chongqing Huapont Pharmaceutical Business Overview
Table 113. Chongqing Huapont Pharmaceutical Anti-allergic Drugs Product
Table 114. Chongqing Huapont Pharmaceutical Revenue in Anti-allergic Drugs Business (2017-2022) & (US$ Million)
Table 115. Chongqing Huapont Pharmaceutical Recent Developments
Table 116. Dawnrays Company Details
Table 117. Dawnrays Business Overview
Table 118. Dawnrays Anti-allergic Drugs Product
Table 119. Dawnrays Revenue in Anti-allergic Drugs Business (2017-2022) & (US$ Million)
Table 120. Dawnrays Recent Developments
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Anti-allergic Drugs Market Share by Type: 2021 VS 2028
Figure 2. Oral Drugs Features
Figure 3. Non-Oral Drugs Features
Figure 4. Global Anti-allergic Drugs Market Share by Sales Channel: 2021 VS 2028
Figure 5. Online Case Studies
Figure 6. Offline Case Studies
Figure 7. Anti-allergic Drugs Report Years Considered
Figure 8. Global Anti-allergic Drugs Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 9. Global Anti-allergic Drugs Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 10. Global Anti-allergic Drugs Market Share by Region: 2021 VS 2028
Figure 11. Global Anti-allergic Drugs Market Share by Players in 2021
Figure 12. Global Top Anti-allergic Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-allergic Drugs as of 2021)
Figure 13. The Top 10 and 5 Players Market Share by Anti-allergic Drugs Revenue in 2021
Figure 14. North America Anti-allergic Drugs Market Size YoY (2017-2028) & (US$ Million)
Figure 15. North America Anti-allergic Drugs Market Size Market Share by Type (2017-2028)
Figure 16. North America Anti-allergic Drugs Market Size Market Share by Sales Channel (2017-2028)
Figure 17. North America Anti-allergic Drugs Market Size Share by Country (2017-2028)
Figure 18. United States Anti-allergic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. Canada Anti-allergic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Europe Anti-allergic Drugs Market Size YoY (2017-2028) & (US$ Million)
Figure 21. Europe Anti-allergic Drugs Market Size Market Share by Type (2017-2028)
Figure 22. Europe Anti-allergic Drugs Market Size Market Share by Sales Channel (2017-2028)
Figure 23. Europe Anti-allergic Drugs Market Size Share by Country (2017-2028)
Figure 24. Germany Anti-allergic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. France Anti-allergic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. U.K. Anti-allergic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Italy Anti-allergic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Russia Anti-allergic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Nordic Countries Anti-allergic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Asia-Pacific Anti-allergic Drugs Market Size YoY (2017-2028) & (US$ Million)
Figure 31. Asia Pacific Anti-allergic Drugs Market Size Market Share by Type (2017-2028)
Figure 32. Asia Pacific Anti-allergic Drugs Market Size Market Share by Sales Channel (2017-2028)
Figure 33. Asia Pacific Anti-allergic Drugs Market Size Share by Region (2017-2028)
Figure 34. China Anti-allergic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Japan Anti-allergic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. South Korea Anti-allergic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Southeast Asia Anti-allergic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. India Anti-allergic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Australia Anti-allergic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Latin America Anti-allergic Drugs Market Size YoY (2017-2028) & (US$ Million)
Figure 41. Latin America Anti-allergic Drugs Market Size Market Share by Type (2017-2028)
Figure 42. Latin America Anti-allergic Drugs Market Size Market Share by Sales Channel (2017-2028)
Figure 43. Latin America Anti-allergic Drugs Market Size Share by Country (2017-2028)
Figure 44. Mexico Anti-allergic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Brazil Anti-allergic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Middle East & Africa Anti-allergic Drugs Market Size YoY (2017-2028) & (US$ Million)
Figure 47. Middle East and Africa Anti-allergic Drugs Market Size Market Share by Type (2017-2028)
Figure 48. Middle East and Africa Anti-allergic Drugs Market Size Market Share by Sales Channel (2017-2028)
Figure 49. Middle East and Africa Anti-allergic Drugs Market Size Share by Country (2017-2028)
Figure 50. Turkey Anti-allergic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 51. Saudi Arabia Anti-allergic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 52. UAE Anti-allergic Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. Sanofi Revenue Growth Rate in Anti-allergic Drugs Business (2017-2022)
Figure 54. Johnson And Johnson Revenue Growth Rate in Anti-allergic Drugs Business (2017-2022)
Figure 55. Merck Revenue Growth Rate in Anti-allergic Drugs Business (2017-2022)
Figure 56. Teva Revenue Growth Rate in Anti-allergic Drugs Business (2017-2022)
Figure 57. GlaxoSmithKline Revenue Growth Rate in Anti-allergic Drugs Business (2017-2022)
Figure 58. Bayer Revenue Growth Rate in Anti-allergic Drugs Business (2017-2022)
Figure 59. Sun Pharma Revenue Growth Rate in Anti-allergic Drugs Business (2017-2022)
Figure 60. UCB Pharma Revenue Growth Rate in Anti-allergic Drugs Business (2017-2022)
Figure 61. Yangtze River Pharmaceutical Group Revenue Growth Rate in Anti-allergic Drugs Business (2017-2022)
Figure 62. Hainan Poly Pharm Revenue Growth Rate in Anti-allergic Drugs Business (2017-2022)
Figure 63. Chongqing Huapont Pharmaceutical Revenue Growth Rate in Anti-allergic Drugs Business (2017-2022)
Figure 64. Dawnrays Revenue Growth Rate in Anti-allergic Drugs Business (2017-2022)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed

---